Competitors Say Medtronic’s ICD Lead Issues Are Company Specific

The GMP Letter
Following Medtronic’s large-scale recall of internal cardioverter defibrillator (ICD) leads, both St. Jude Medical and Boston Scientific are not concerned their leads will suffer a similar fate.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $20.00